Literature DB >> 29234251

Targeted Intraoperative Radiotherapy Tumour Bed Boost during Breast-Conserving Surgery after Neoadjuvant Chemotherapy.

Jayant S Vaidya1, Jeffrey S Tobias1.   

Abstract

Year:  2017        PMID： 29234251      PMCID： PMC5704699          DOI： 10.1159/000479726

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  14 in total

1.  Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

Authors:  Davide Mauri; Nicholas Pavlidis; John P A Ioannidis
Journal:  J Natl Cancer Inst       Date:  2005-02-02       Impact factor: 13.506

Review 2.  Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials.

Authors:  Jayant S Vaidya; Max Bulsara; Frederik Wenz; Nathan Coombs; Julian Singer; Stephen Ebbs; Samuele Massarut; Christobel Saunders; Michael Douek; Norman R Williams; David Joseph; Jeffrey S Tobias; Michael Baum
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-05-13       Impact factor: 7.038

3.  Risk of second primary lung cancer in women after radiotherapy for breast cancer.

Authors:  Trine Grantzau; Mette Skovhus Thomsen; Michael Væth; Jens Overgaard
Journal:  Radiother Oncol       Date:  2014-06-05       Impact factor: 6.280

4.  Risk of ischemic heart disease in women after radiotherapy for breast cancer.

Authors:  Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

5.  An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Christobel Saunders; Chris Brew-Graves; Ingrid Potyka; Stephen Morris; Hrisheekesh J Vaidya; Norman R Williams; Michael Baum
Journal:  Health Technol Assess       Date:  2016-09       Impact factor: 4.014

6.  Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer.

Authors:  Jayant S Vaidya; Max Bulsara; Frederik Wenz; David Joseph; Christobel Saunders; Samuele Massarut; Henrik Flyger; Wolfgang Eiermann; Michael Alvarado; Laura Esserman; Mary Falzon; Chris Brew-Graves; Ingrid Potyka; Jeffrey S Tobias; Michael Baum
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-08       Impact factor: 7.038

Review 7.  Preoperative chemotherapy for women with operable breast cancer.

Authors:  J S D Mieog; J A van der Hage; C J H van de Velde
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18

8.  Ischemic heart disease after breast cancer radiotherapy.

Authors:  Jayant S Vaidya; Max Bulsara; Frederik Wenz
Journal:  N Engl J Med       Date:  2013-06-27       Impact factor: 91.245

9.  Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer.

Authors:  K E Henson; P McGale; C Taylor; S C Darby
Journal:  Br J Cancer       Date:  2012-12-20       Impact factor: 7.640

10.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Mohammed Keshtgar; Henrik L Flyger; Samuele Massarut; Michael Alvarado; Christobel Saunders; Wolfgang Eiermann; Marinos Metaxas; Elena Sperk; Marc Sütterlin; Douglas Brown; Laura Esserman; Mario Roncadin; Alastair Thompson; John A Dewar; Helle M R Holtveg; Steffi Pigorsch; Mary Falzon; Eleanor Harris; April Matthews; Chris Brew-Graves; Ingrid Potyka; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.